Helicobacter pylori-related gastroenterology studies

Helicobacter pylori is a bacterial pathogen that colonizes the gastric mucosa in roughly half the world's population, and its persistent infection is now recognized as the leading cause of gastric cancer, a disease that remains one of the deadliest malignancies worldwide. Researchers in this area investigate how the bacterium triggers chronic inflammation, damages the stomach lining, and interacts with host genetic factors — such as interleukin-1 polymorphisms — to drive the progression from gastritis to malignancy. A central practical challenge is that antibiotic resistance is eroding the effectiveness of standard eradication regimens, prompting active work on alternative treatment combinations and the timing of intervention. A deeper open question is how precisely to identify which infected individuals are at elevated cancer risk, so that eradication therapy and surgical decisions can be targeted before irreversible mucosal changes take hold.

Works

154,883

Total citations

2,200,404

Keywords

Gastric CancerHelicobacter pyloriInflammationAntibiotic ResistanceEradication TherapyPathogenesis